Sign In

Eric Topol

Physician-Scientist, Author, Editor

Eric Topol, MD is a prominent physician-scientist, author, and editor based in San Diego County, California.1 He is the Founder and Director of the Scripps Research Translational Institute at The Scripps Research Institute, a position he has held since January 2007.1

Professional Background

Dr. Topol has an extensive career in medicine and research:

  • Executive Vice President at Scripps Research (September 2017 - Present)
  • Professor of Molecular Medicine at Scripps Research (September 2017 - Present)
  • Cardiologist at Scripps Health (January 2007 - Present)

Previously, he served as:

  • Chief Academic Officer at Scripps Health (2007-2017)
  • Vice-Chairman at West Wireless Health Institute (2009-2012)
  • Chairman of the Department of Cardiovascular Medicine at Cleveland Clinic (1991-2006)

Education

Dr. Topol received his education from prestigious institutions:

  • MD with Honor from the University of Rochester (1975-1979)
  • BA with Highest Distinction in Biomedicine from the University of Virginia (1971-1975)

Research Focus

Eric Topol specializes in cardiology, genetics, genomics, precision medicine, artificial intelligence, deep learning, and digital medicine.1 He is particularly interested in how emerging technologies are reshaping the future of medicine, including:

  • Sensors
  • Genomics
  • Imaging
  • Advanced analytics
  • Artificial intelligence and deep learning

Publications

Dr. Topol is an author, with his latest book titled "Deep Medicine" exploring how artificial intelligence can improve healthcare by allowing doctors to focus more on human connection and patient care.1

Eric Topol is a visionary in the field of medicine, working at the intersection of technology and healthcare to advance medical understanding and patient care.

Highlights

Jul 20 · NPR
Why some folks never got sick from COVID: It could be in their genes ... - NPR
Why some folks never got sick from COVID: It could be in their genes ... - NPR
May 9 · Bloomberg Law
AI Drug Discovery Is a $50 Billion Opportunity for Big Pharma - Bloomberg Law
AI Drug Discovery Is a $50 Billion Opportunity for Big Pharma - Bloomberg Law

Related Questions

What are some of Eric Topol's most notable contributions to the field of medicine?
How has Eric Topol's work impacted the use of artificial intelligence in healthcare?
What is the main focus of Eric Topol's book "Deep Medicine"?
Can you provide examples of Eric Topol's research at the Scripps Research Translational Institute?
What are Eric Topol's views on the future of precision medicine?
Eric Topol
Eric Topol, photo 1
Eric Topol, photo 2
Add to my network

Experience

Founder and Director at Scripps Research Translational Institute
Executive Vice President at Scripps Research since September 2017; Professor of Molecular Medicine at Scripps Research since September 2017; Former Chairman of Cardiovascular Medicine at Cleveland Clinic (June 1991 - January 2006)

Education

MD With Honor, Medicine from University of Rochester (1975 - 1979); BA With Highest Distinction, Biomedicine from University of Virginia (1971 - 1975)

Location

San Diego County, California, United States